KATHERINE CHOJNICKI: Open Payments
NPI 1831697713 · WILLIAMSVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,530 in 36 payments from 9 companies in 2025. Trend: 2023 $721 · 2024 $504 · 2025 $1,530
Long term medical supply or device loan: $897Food & beverage: $609Education: $23
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 15 | $1,072 |
| ABBVIE INC. | 7 | $148 |
| AstraZeneca Pharmaceuticals LP | 4 | $88 |
| PFIZER INC. | 3 | $74 |
| Celgene Corporation | 2 | $41 |
| Astellas Pharma US Inc | 2 | $37 |
| Lilly USA, LLC | 1 | $26 |
| Tactile Systems Technology Inc | 1 | $23 |
| SHIELD THERAPEUTICS INC | 1 | $21 |
Products named: KISQALI, EPKINLY, PLUVICTO, ELREXFIO, REBLOZYL, VYNDAQEL, VENCLEXTA, CALQUENCE.
Industry payments across NY — which companies pay providers there.
